Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 10 | $138,419 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
01 Sep 2023 19:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 01 Sep 2023 | Sale | 2,403 | 0.78 | 1,874 | D |
27 Jun 2023 21:15 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 27 Jun 2023 | Sale | 2,333 | 0.92 | 2,146 | D |
17 Jan 2024 17:31 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 16 Jan 2024 | Sale | 9,304 | 0.79 | 7,350 | D |
04 Jan 2023 21:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 04 Jan 2023 | Sale | 5,073 | 1.694 | 8,594 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 11 Jan 2024 | Sale | 11,945 | 0.8367 | 9,994 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 12 Jan 2024 | Sale | 17,257 | 0.8541 | 14,739 | D |
17 Jan 2023 21:15 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 17 Jan 2023 | Sale | 10,057 | 1.858 | 18,686 | D |
17 Jan 2024 17:31 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 17 Jan 2024 | Sale | 30,080 | 0.673 | 20,244 | D |
12 Jan 2023 21:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 11 Jan 2023 | Sale | 13,042 | 1.7468 | 22,782 | D |
12 Jan 2023 21:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 12 Jan 2023 | Sale | 18,763 | 1.706 | 32,010 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)